AstraZeneca PLC (AZN) operating KPIs
AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)
Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%
AstraZeneca pSP — Unvested awards outstanding over ADSs (ADSs)
Form 20-F Note 29 — Share-Based Payments
Latest, FY2025
5,790
Period ended Dec 31, 2025
Change on a year earlier
-5.9%
6,150 in FY2024
History
7 years
Since FY2019
Sources
3
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | PSP — Unvested awards outstanding over ADSs (ADSs) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 5,790 | -5.9% | Form 20-F FY2025 Annual Report ↗ |
| FY2024 | Dec 31, 2024 | 6,150 | +4.4% | Form 20-F FY2025 Annual Report ↗ |
| FY2023 | Dec 31, 2023 | 5,888 | +2.9% | Form 20-F FY2025 Annual Report ↗ |
| FY2022 | Dec 31, 2022 | 5,724 | +10.5% | Form 20-F FY2025 Annual Report ↗ |
| FY2021 | Dec 31, 2021 | 5,178 | +8.1% | Form 20-F FY2024 Annual Report ↗ |
| FY2020 | Dec 31, 2020 | 4,791 | -8.0% | Form 20-F FY2023 Annual Report ↗ |
| FY2019 | Dec 31, 2019 | 5,206 | – | Form 20-F FY2023 Annual Report ↗ |
Cite this data
StockData. (2026). AstraZeneca PSP — Unvested awards outstanding over ADSs (ADSs), annual FY2019–FY2025 [Data set]. Compiled from AstraZeneca SEC filings and investor materials. https://stockdatahq.com/stocks/azn/kpis/sbc_out_psp_adr
See every metric in the AstraZeneca KPI table. Data updated Oct 28, 2026.